Clinical Trials Directory

Trials / Completed

CompletedNCT06145685

Effect of Smoking Cessation on Salivary IL-1β and PGE-2 Levels Following Non-Surgical Periodontal Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
October 6 University · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to evaluate the effect of smoking cessation on inflammatory markers following non-surgical treatment of periodontal disease. This is to assess the period of smoking abstinence needed before any periodontal surgery in order to reverse the negative effects of the reported increased levels of inflammatory markers (IL-1β and PGE2 in this study) associated with smoking on the healing and the periodontium.

Conditions

Interventions

TypeNameDescription
PROCEDUREMinimally invasive non-surgical periodontal therapyMinimally invasive non-surgical periodontal therapy
PROCEDUREConventional non-surgical periodontal therapyConventional non-surgical periodontal therapy

Timeline

Start date
2021-01-01
Primary completion
2022-02-28
Completion
2022-02-28
First posted
2023-11-24
Last updated
2023-11-24

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06145685. Inclusion in this directory is not an endorsement.

Effect of Smoking Cessation on Salivary IL-1β and PGE-2 Levels Following Non-Surgical Periodontal Therapy (NCT06145685) · Clinical Trials Directory